2nd Annual Pharma Pricing , Reimbrusement & Market Access 2016

Key Topics

• EU and US policy challenges for market : Stepping ahead
• Preparing best market access strategy
• Current future - Challenges opportunities in pharma pricing, reimbursement market
• Unrivalled opportunity to expose and the market access challenges facing the industry
• Measurement strategies through to in-depth knowledge regarding payer formulary coverage trends
• Improving patient and market through the development of targeted value propositions, comprehensive contract assessment
• Payers perspective
• How can payers and industry work together to that innovative and valuable treatments make it to the market?
• Creating a robust patient services and reimbursement program for biosimilar products
• Advocating and collaborating with payers for value in a new era
• How price affects market [[ access ]] and learn on how to set prices for optimal access and returns
• Prioritising Patients! - Adding value through an innovative patient-centered approach
• Evidence Generation - The strategic rigor and creativity applied to evidence generation
• New drugs are failing to reimbursement from payers/HTAs at an alarming rate, despite being approved by regulators
• Developing -sharing reimbursement models and value based pricing
• Impact of social media and digital analytics
• Explaining how to the data sources and observational research for effective safety analysis
• Patient engagement and adherence within the environment
• Accelerating new medicine introduction in developing world overcoming challenges
• Dwell ahead of regulatory developments improving strategies in a cost effective way in EU, US

Who should Attend

Senior attendees with responsibilities in:

• Reimbursement
• Pricing
• Commercial Pricing
• Market Access
• Health Economics
• Pricing Strategists
• Regulatory Affairs
• Outcomes Research
• Public Affairs
• Governmental Affairs
• Operations
• Public Policy Directors
• Regulatory bodies
• Governmental bodies